For: | D’Aoust J, Battat R, Bessissow T. Management of inflammatory bowel disease with Clostridium difficile infection. World J Gastroenterol 2017; 23(27): 4986-5003 [PMID: 28785153 DOI: 10.3748/wjg.v23.i27.4986] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i27/4986.htm |
Number | Citing Articles |
1 |
Aleksandra Tarasiuk, Guido Eibl. Nutritional Support and Probiotics as a Potential Treatment of IBD. Current Drug Targets 2020; 21(14): 1417 doi: 10.2174/1389450121666200504075519
|
2 |
Bhairavi Balram, Robert Battat, Alex Al-Khoury, Julie D’Aoust, Waqqas Afif, Alain Bitton, Peter L Lakatos, Talat Bessissow. Risk Factors Associated withClostridium difficileInfection in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Journal of Crohn's and Colitis 2019; 13(1): 27 doi: 10.1093/ecco-jcc/jjy143
|
3 |
Krista Vitikainen, Johanna Haapamäki, Martti Färkkilä, Veli-Jukka Anttila, Perttu Arkkila. Clostridium difficile infection in patients with inflammatory bowel disease: a case control study. Scandinavian Journal of Gastroenterology 2018; 53(8): 947 doi: 10.1080/00365521.2018.1492012
|
4 |
C. Rodríguez, E. Romero, L. Garrido-Sanchez, G. Alcaín-Martínez, RJ. Andrade, B. Taminiau, G. Daube, E. García-Fuentes. MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE. Gut Microbes 2020; 12(1): 1725220 doi: 10.1080/19490976.2020.1725220
|
5 |
Angela Y. Lam, Liat S. Gutin, Yume Nguyen, Fernando S. Velayos. Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients. Digestive Diseases and Sciences 2020; 65(11): 3111 doi: 10.1007/s10620-020-06521-x
|
6 |
Annick Moens, Bram Verstockt, Kathleen Machiels, Peter Bossuyt, Ann Verdonck, Katrien Lagrou, Gert van Assche, Séverine Vermeire, Marc Ferrante. Clostridium difficile infection in inflammatory bowel disease: epidemiology over two decades. European Journal of Gastroenterology & Hepatology 2019; 31(6): 668 doi: 10.1097/MEG.0000000000001394
|
7 |
Sibel Bolukcu, IsmailNecati Hakyemez, BilgeSumbul Gultepe, Gulay Okay, Bulent Durdu, MelihaMeric Koc, Turan Aslan. Clostridium difficile infection: Is there a change in the underlying factors? Inflammatory bowel disease and Clostridium difficile. Saudi Journal of Gastroenterology 2019; 25(6): 0 doi: 10.4103/sjg.SJG_44_19
|
8 |
Annu Gupta, Christopher Wash, Yingxing Wu, Dario Sorrentino, Vu Q. Nguyen. Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease. Digestive Diseases and Sciences 2021; 66(2): 547 doi: 10.1007/s10620-020-06205-6
|
9 |
Lijun Dong, Jingwen Xie, Youyi Wang, Daming Zuo. Gut Microbiota and Pathogenesis of Organ Injury. Advances in Experimental Medicine and Biology 2020; 1238: 165 doi: 10.1007/978-981-15-2385-4_10
|
10 |
Emily R Jonica, Carol A Sulis, Kanupriya Soni, Michelle Hughes, Eric Jones, Janice Weinberg, Nancy S Miller, Francis A Farraye. Role of Cycle Threshold in Clostridioides difficile Polymerase Chain Reaction Testing as a Predictor of Clinical Outcomes in Patients With Inflammatory Bowel Disease. Crohn's & Colitis 360 2019; 1(3) doi: 10.1093/crocol/otz036
|
11 |
Le Su, Feifan Ma, Zaiyong An, Xiuyu Ji, Ping Zhang, Qiulin Yue, Chen Zhao, Xin Sun, Kunlun Li, Baojun Li, Xinli Liu, Lin Zhao. The Metabolites of Lactobacillus fermentum F-B9-1 Relieved Dextran Sulfate Sodium-Induced Experimental Ulcerative Colitis in Mice. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.865925
|
12 |
Najmeh Aletaha, Zohreh Dadvar, Babak Salehi, Pardis Ketabi Moghadam, Ali Niksirat, Akram Jowkar, Reza Taslimi, Seyed Farshad Allameh, Naser Ebrahimi Daryani. Clinical and Pathological Features of Ulcerative Colitis in Patients with and without Clostridium Difficile Infection; An Observational Study. Middle East Journal of Digestive Diseases 2018; 11(1): 17 doi: 10.15171/mejdd.2018.123
|
13 |
Joshua L. Hudson, Edward L. Barnes. Management of Inpatient Inflammatory Bowel Disease. 2022; : 211 doi: 10.1007/978-1-0716-1987-2_10
|
14 |
Kang-Moon Lee. Monitoring Disease Activity: How and When?. The Korean Journal of Gastroenterology 2018; 71(2): 69 doi: 10.4166/kjg.2018.71.2.69
|
15 |
Daisuke Oka, Naomitsu Yamaya, Takuya Kuno, Yuta Asakawa, Toshiyuki Shiragiku, Liang Chen, Jingbo Xue, Abudusaimi Mamuti, Fangguo Ye, Jiangqin Sun, Kinue Ohguro, Hisashi Miyamoto, Yukitaka Uematsu, Katsuya Inagaki, Jie-Fei Cheng, Makoto Matsumoto.
In Vitro
and
In Vivo
Antibacterial Activities of a Novel Quinolone Compound, OPS-2071, against Clostridioides difficile
. Antimicrobial Agents and Chemotherapy 2021; 65(4) doi: 10.1128/AAC.01170-20
|
16 |
Raquel Linares, Rubén Francés, Ana Gutiérrez, Oriol Juanola. Bacterial Translocation as Inflammatory Driver in Crohn’s Disease. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.703310
|
17 |
Lilia Davenport, Jamie Chin-Hon, Juri Chung, Xian Jie Cindy Chen, Jeffrey Schneider. 6-Mercaptopurine and Macrophage Activation Syndrome Case Report and Review of the Literature. Journal of Pharmacy Practice 2022; : 089719002210816 doi: 10.1177/08971900221081617
|
18 |
Puo-Hsien Le, Cheng-Tang Chiu, Pai-Jui Yeh, Yu-Bin Pan, Cheng-Hsun Chiu. Clostridium innocuum infection in hospitalised patients with inflammatory bowel disease. Journal of Infection 2022; 84(3): 337 doi: 10.1016/j.jinf.2021.12.031
|
19 |
Abin Chandrakumar, Hussein Zohni, Wael El-Matary.
Clostridioides difficile Infection in Children With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2020; 26(11): 1700 doi: 10.1093/ibd/izz285
|
20 |
Jakob Seidelin, Johan Burisch. Biomarkers in Inflammatory Bowel Diseases. 2019; : 281 doi: 10.1007/978-3-030-11446-6_23
|
21 |
Lizhi Zhang, Tsung-Teh Wu. Surgical Pathology of Non-neoplastic Gastrointestinal Diseases. 2019; : 373 doi: 10.1007/978-3-030-15573-5_15
|
22 |
Seth R. Shaffer, Zoann Nugent, Charles N. Bernstein, Andrew Walkty, Harminder Singh. Effect of clinical versus administrative data definitions on the epidemiology of C. difficile among hospitalized individuals with IBD: a population-based cohort study. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02223-y
|
23 |
Xiujuan Lei, Yueyue Wang. Predicting Microbe-Disease Association by Learning Graph Representations and Rule-Based Inference on the Heterogeneous Network. Frontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.00579
|
24 |
Antonietta D’Errico, Deborah Malvi. Ulcerative Colitis. Updates in Surgery 2019; : 61 doi: 10.1007/978-88-470-3977-3_5
|
25 |
Rahul S. Dalal, Jessica R. Allegretti. Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease. Current Opinion in Gastroenterology 2021; 37(4): 336 doi: 10.1097/MOG.0000000000000739
|
26 |
Trusha Nana, Chanelle Moore, Tom Boyles, Adrian J. Brink, Joy Cleghorn, Lesley M. Devenish, Briette du Toit, Ernst S. Fredericks, Molebogeng R. Lekalakala-Mokaba, Caroline Maluleka, Muhammad N. Rajabally, Gary Reubenson, Liliwe Shuping, Karin Swart, Khine Swe Swe Han, Jeannette Wadula, Justyna Wojno, Warren Lowman. South African Society of Clinical Microbiology Clostridioides difficile infection diagnosis, management and infection prevention and control guideline. Southern African Journal of Infectious Diseases 2020; 35(1) doi: 10.4102/sajid.v35i1.219
|
27 |
Sara El Ouali, Jean-Paul Achkar. Management of Inpatient Inflammatory Bowel Disease. 2022; : 161 doi: 10.1007/978-1-0716-1987-2_8
|
28 |
Xiaoyu Yang, Linai Kuang, Zhiping Chen, Lei Wang. Multi-Similarities Bilinear Matrix Factorization-Based Method for Predicting Human Microbe–Disease Associations. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.754425
|
29 |
Parisa Shoaei, Hasan Shojaei, Mohammad Jalali, Farzin Khorvash, Sayed Mohsen Hosseini, Behrooz Ataei, Bahareh Vakili, Fatemeh Ebrahimi, Hossein Tavakoli, Zahra Esfandiari, J. Scott Weese. Clostridium difficile isolated from faecal samples in patients with ulcerative colitis. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-3965-8
|